Post-Event Update: Biotts’ Showcase at Bio Europe 2023

Bio Europe 2023 in Munich was a huge success for Biotts.

Read more

We are presenting at Bioeurope 2023 Munich

Join us at BioEurope 2023 in Munich!
We’re thrilled to extend a warm invitation to you for our exclusive presentation on November 6th at 3:30 pm.

Read more

Meet BIOTTS at CPHI Barcelona

At BIOTTS we are gearing up for this year’s CPHI Worldwide event happening in Barcelona. It’s a fantastic opportunity to present the new possibilities of our innovative transdermal delivery technology, capable of transporting large molecules such as proteins and peptides through the skin. We’re thrilled to be a part of it!

Read more

Biotts launches new website showcasing breakthrough transdermal drug delivery technology

We are thrilled to unveil our brand-new website, showcasing the revolutionary Multifunctional Transdermal Carrier Y (MTC-Y™) technology developed by Biotts, a global leader in Transdermal Drug Delivery.

Read more

Biotts team at the annual conference Advanced Technologies & Treatments for Diabetes (ATTD) 2023

Our Biotts team – Dr. Paweł Biernat, CEO & Transdermal Systems Specialist, and Jan Hendriks, CBO, took part in the annual conference Advanced Technologies & Treatments for Diabetes (ATTD) 2023 in Berlin.

Read more

Biotts granted GMP license to manufacture and import medicinal products

It’s official: Biotts has reached another important milestone in its development!
The Chief Pharmaceutical Inspectorate has granted Biotts a license to manufacture and import medicinal products – thanks to this consent, our scientists can start clinical trials on humans in the first quarter of 2023.

Read more